Tern
London-listed investor in UK companies building disruptive technology across health, IoT and security.
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Seed, Series A, Growth
- Sector focus
- Healthtech, Cybersecurity, Hardware & Robotics
- Fund size
- Undisclosed
- Founded
- 2004
- Website
- ternplc.com
Tern is a London-based investment company that takes stakes in UK businesses developing disruptive technology. It describes its portfolio as companies that start local but aim to grow globally, with holdings across healthcare, cybersecurity and the internet of things. Current investments include Talking Medicines, which builds patient advocacy and pharmaceutical intelligence tools; FundamentalVR, a provider of virtual-reality surgical training; and Device Authority, which secures identity and data for connected devices. As a quoted company it gives public market investors exposure to a concentrated portfolio of growing private technology companies.
Team
- Al Sisto, CEO LinkedIn
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.